rs4684677

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016362.5(GHRL):​c.269A>T​(p.Gln90Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0696 in 1,612,592 control chromosomes in the GnomAD database, including 6,949 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 727 hom., cov: 33)
Exomes 𝑓: 0.070 ( 6222 hom. )

Consequence

GHRL
NM_016362.5 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 4.09

Publications

79 publications found
Variant links:
Genes affected
GHRL (HGNC:18129): (ghrelin and obestatin prepropeptide) This gene encodes the ghrelin-obestatin preproprotein that is cleaved to yield two peptides, ghrelin and obestatin. Ghrelin is a powerful appetite stimulant and plays an important role in energy homeostasis. Its secretion is initiated when the stomach is empty, whereupon it binds to the growth hormone secretagogue receptor in the hypothalamus which results in the secretion of growth hormone (somatotropin). Ghrelin is thought to regulate multiple activities, including hunger, reward perception via the mesolimbic pathway, gastric acid secretion, gastrointestinal motility, and pancreatic glucose-stimulated insulin secretion. It was initially proposed that obestatin plays an opposing role to ghrelin by promoting satiety and thus decreasing food intake, but this action is still debated. Recent reports suggest multiple metabolic roles for obestatin, including regulating adipocyte function and glucose metabolism. Alternative splicing results in multiple transcript variants. In addition, antisense transcripts for this gene have been identified and may potentially regulate ghrelin-obestatin preproprotein expression. [provided by RefSeq, Nov 2014]
GHRLOS (HGNC:33885): (ghrelin opposite strand/antisense RNA) This gene is an antisense gene of the ghrelin/obestatin prepropeptide gene. Alternatively spliced transcript variants have been identified and they may function as non-coding regulatory RNAs. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018431842).
BP6
Variant 3-10286769-T-A is Benign according to our data. Variant chr3-10286769-T-A is described in ClinVar as Benign. ClinVar VariationId is 5063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHRLNM_016362.5 linkc.269A>T p.Gln90Leu missense_variant Exon 5 of 6 ENST00000335542.13 NP_057446.1 Q9UBU3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHRLENST00000335542.13 linkc.269A>T p.Gln90Leu missense_variant Exon 5 of 6 1 NM_016362.5 ENSP00000335074.8 Q9UBU3-1

Frequencies

GnomAD3 genomes
AF:
0.0666
AC:
10129
AN:
152170
Hom.:
718
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0151
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.210
Gnomad ASJ
AF:
0.0449
Gnomad EAS
AF:
0.00673
Gnomad SAS
AF:
0.0598
Gnomad FIN
AF:
0.139
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0613
Gnomad OTH
AF:
0.0636
GnomAD2 exomes
AF:
0.104
AC:
26029
AN:
251244
AF XY:
0.0936
show subpopulations
Gnomad AFR exome
AF:
0.0119
Gnomad AMR exome
AF:
0.370
Gnomad ASJ exome
AF:
0.0401
Gnomad EAS exome
AF:
0.00566
Gnomad FIN exome
AF:
0.139
Gnomad NFE exome
AF:
0.0629
Gnomad OTH exome
AF:
0.0872
GnomAD4 exome
AF:
0.0700
AC:
102169
AN:
1460304
Hom.:
6222
Cov.:
29
AF XY:
0.0685
AC XY:
49801
AN XY:
726532
show subpopulations
African (AFR)
AF:
0.0108
AC:
360
AN:
33458
American (AMR)
AF:
0.354
AC:
15802
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.0408
AC:
1067
AN:
26132
East Asian (EAS)
AF:
0.0128
AC:
509
AN:
39686
South Asian (SAS)
AF:
0.0624
AC:
5377
AN:
86210
European-Finnish (FIN)
AF:
0.138
AC:
7377
AN:
53388
Middle Eastern (MID)
AF:
0.0277
AC:
160
AN:
5766
European-Non Finnish (NFE)
AF:
0.0611
AC:
67872
AN:
1110650
Other (OTH)
AF:
0.0604
AC:
3645
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
3993
7985
11978
15970
19963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2606
5212
7818
10424
13030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0666
AC:
10142
AN:
152288
Hom.:
727
Cov.:
33
AF XY:
0.0716
AC XY:
5334
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0151
AC:
626
AN:
41566
American (AMR)
AF:
0.211
AC:
3226
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0449
AC:
156
AN:
3472
East Asian (EAS)
AF:
0.00674
AC:
35
AN:
5190
South Asian (SAS)
AF:
0.0592
AC:
286
AN:
4828
European-Finnish (FIN)
AF:
0.139
AC:
1478
AN:
10600
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0613
AC:
4167
AN:
68024
Other (OTH)
AF:
0.0630
AC:
133
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
462
923
1385
1846
2308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0610
Hom.:
155
Bravo
AF:
0.0726
TwinsUK
AF:
0.0612
AC:
227
ALSPAC
AF:
0.0602
AC:
232
ESP6500AA
AF:
0.0143
AC:
63
ESP6500EA
AF:
0.0590
AC:
507
ExAC
AF:
0.0904
AC:
10981
Asia WGS
AF:
0.0470
AC:
163
AN:
3478
EpiCase
AF:
0.0573
EpiControl
AF:
0.0577

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23251435, 12050239, 25540946, 23084284) -

Obesity Other:1
Jun 01, 2002
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T;.;.;.;.;T;.;T
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.83
.;.;T;T;T;.;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M;.;.;.;.;M;.;M
PhyloP100
4.1
PrimateAI
Benign
0.34
T
PROVEAN
Pathogenic
-4.7
D;D;D;D;D;D;D;D
REVEL
Benign
0.17
Sift
Benign
0.13
T;T;D;D;T;T;D;T
Sift4G
Benign
0.085
T;T;D;D;T;T;D;T
Polyphen
1.0
D;D;D;D;D;D;D;D
Vest4
0.40
MPC
0.053
ClinPred
0.026
T
GERP RS
4.8
Varity_R
0.29
gMVP
0.60
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4684677; hg19: chr3-10328453; COSMIC: COSV55055549; COSMIC: COSV55055549; API